
TY  - JOUR
TI  - Poster Session TPS 1-18
JO  - Allergy
JA  - Allergy
VL  - 71
IS  - S102
SN  - 0105-4538
UR  - https://doi.org/10.1111/all.12974
DO  - doi:10.1111/all.12974
SP  - 300
EP  - 389
PY  - 2016
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - The FEBS Journal
JA  - FEBS J
VL  - 282
IS  - S1
SN  - 1742-464X
UR  - https://doi.org/10.1111/febs.13339
DO  - doi:10.1111/febs.13339
SP  - 55
EP  - 422
PY  - 2015
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - American Journal of Transplantation
VL  - 11
IS  - s2
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2011.03533.x
DO  - doi:10.1111/j.1600-6143.2011.03533.x
SP  - 28
EP  - 211
PY  - 2011
ER  - 

TY  - JOUR
TI  - 2016 ACVIM Forum Research Abstract Program
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 30
IS  - 4
SN  - 0891-6640
UR  - https://doi.org/10.1111/jvim.13952
DO  - doi:10.1111/jvim.13952
SP  - 1407
EP  - 1519
PY  - 2016
ER  - 

TY  - JOUR
TI  - Abstracts Oral
JO  - American Journal of Transplantation
VL  - 8
IS  - s2
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2008.02254.x
DO  - doi:10.1111/j.1600-6143.2008.02254.x
SP  - 177
EP  - 336
PY  - 2008
ER  - 

TY  - JOUR
TI  - Plenary Lectures
JO  - Experimental Dermatology
JA  - Exp Dermatol
VL  - 28
IS  - S2
SN  - 0906-6705
UR  - https://doi.org/10.1111/exd.13893
DO  - doi:10.1111/exd.13893
SP  - 5
EP  - 55
PY  - 2019
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 19
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.833
DO  - doi:10.1002/ejhf.833
SP  - 5
EP  - 601
PY  - 2017
ER  - 

TY  - JOUR
AU  - Malchesky, Paul S.
TI  - Artificial Organs 2017: A Year in Review
JO  - Artificial Organs
JA  - Artificial Organs
VL  - 42
IS  - 3
SN  - 0160-564X
UR  - https://doi.org/10.1111/aor.13137
DO  - doi:10.1111/aor.13137
SP  - 305
EP  - 331
KW  - Apheresis
KW  - —Artificial blood
KW  - —Bioengineering
KW  - —Blood pumps
KW  - —Cardiac support
KW  - —Cardiopulmonary
KW  - —Dermal
KW  - —Dialysis
KW  - —Functional electrical stimulation
KW  - —Medical devices
KW  - —Membrane oxygenation
KW  - —Organ preservation
KW  - —Orthopedic
KW  - —Pulmonary
KW  - —Renal
KW  - —Tissue engineering
KW  - —Transplantation
KW  - —Valves
KW  - —Vascular
KW  - —Vision
PY  - 2018
AB  - Abstract In this Editor's Review, articles published in 2017 are organized by category and summarized. We provide a brief reflection of the research and progress in artificial organs intended to advance and better human life while providing insight for continued application of these technologies and methods. Artificial Organs continues in the original mission of its founders ?to foster communications in the field of artificial organs on an international level.? Artificial Organs continues to publish developments and clinical applications of artificial organ technologies in this broad and expanding field of organ Replacement, Recovery, and Regeneration from all over the world. Peer-reviewed Special Issues this year included contributions from the 12th International Conference on Pediatric Mechanical Circulatory Support Systems and Pediatric Cardiopulmonary Perfusion edited by Dr. Akif Undar, Artificial Oxygen Carriers edited by Drs. Akira Kawaguchi and Jan Simoni, the 24th Congress of the International Society for Mechanical Circulatory Support edited by Dr. Toru Masuzawa, Challenges in the Field of Biomedical Devices: A Multidisciplinary Perspective edited by Dr. Vincenzo Piemonte and colleagues and Functional Electrical Stimulation edited by Dr. Winfried Mayr and colleagues. We take this time also to express our gratitude to our authors for offering their work to this journal. We offer our very special thanks to our reviewers who give so generously of time and expertise to review, critique, and especially provide meaningful suggestions to the author's work whether eventually accepted or rejected. Without these excellent and dedicated reviewers the quality expected from such a journal could not be possible. We also express our special thanks to our Publisher, John Wiley & Sons for their expert attention and support in the production and marketing of Artificial Organs. We look forward to reporting further advances in the coming years.
ER  - 

TY  - JOUR
TI  - Category Index
JO  - Hepatology
JA  - Hepatology
VL  - 64
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.28802
DO  - doi:10.1002/hep.28802
SP  - 1106
EP  - 1117
PY  - 2016
ER  - 

TY  - JOUR
TI  - Poster Tours
JO  - Pediatric Diabetes
JA  - Pediatr Diabetes
VL  - 14
IS  - s18
SN  - 1399-543X
UR  - https://doi.org/10.1111/pedi.12075
DO  - doi:10.1111/pedi.12075
SP  - 50
EP  - 154
PY  - 2013
ER  - 

TY  - JOUR
TI  - Mini Oral Sessions
JO  - Transplant International
VL  - 24
IS  - s2
SN  - 0934-0874
UR  - https://doi.org/10.1111/j.1432-2277.2011.01349.x
DO  - doi:10.1111/j.1432-2277.2011.01349.x
SP  - 105
EP  - 130
PY  - 2011
ER  - 

TY  - JOUR
TI  - Thursday, 28 July 2011
JO  - Journal of Thrombosis and Haemostasis
VL  - 9
IS  - s2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2011.04380_4.x
DO  - doi:10.1111/j.1538-7836.2011.04380_4.x
SP  - 712
EP  - 959
PY  - 2011
ER  - 

TY  - JOUR
TI  - Research Communications of the 29th ECVIM-CA Congress
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 34
IS  - 1
SN  - 0891-6640
UR  - https://doi.org/10.1111/jvim.15658
DO  - doi:10.1111/jvim.15658
SP  - 339
EP  - 445
PY  - 2020
ER  - 

TY  - JOUR
TI  - AASLD Abstracts
JO  - Hepatology
JA  - Hepatology
VL  - 56
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.26040
DO  - doi:10.1002/hep.26040
SP  - 191A
EP  - 1144A
PY  - 2012
ER  - 

TY  - JOUR
AU  - McIntyre, Roger S
AU  - Cha, Danielle S
AU  - Jerrell, Jeanette M
AU  - Swardfager, Walter
AU  - Kim, Rachael D
AU  - Costa, Leonardo G
AU  - Baskaran, Anusha
AU  - Soczynska, Joanna K
AU  - Woldeyohannes, Hanna O
AU  - Mansur, Rodrigo B
AU  - Brietzke, Elisa
AU  - Powell, Alissa M
AU  - Gallaugher, Ashley
AU  - Kudlow, Paul
AU  - Kaidanovich-Beilin, Oksana
AU  - Alsuwaidan, Mohammad
TI  - Advancing biomarker research: utilizing ‘Big Data’ approaches for the characterization and prevention of bipolar disorder
JO  - Bipolar Disorders
JA  - Bipolar Disord
VL  - 16
IS  - 5
SN  - 1398-5647
UR  - https://doi.org/10.1111/bdi.12162
DO  - doi:10.1111/bdi.12162
SP  - 531
EP  - 547
KW  - Big Data
KW  - biomarkers
KW  - bipolar disorder
KW  - integrated profiles
KW  - prediction
KW  - prodrome
PY  - 2014
AB  - Objective To provide a strategic framework for the prevention of bipolar disorder (BD) that incorporates a ?Big Data? approach to risk assessment for BD. Methods Computerized databases (e.g., Pubmed, PsychInfo, and MedlinePlus) were used to access English-language articles published between 1966 and 2012 with the search terms bipolar disorder, prodrome, ?Big Data?, and biomarkers cross-referenced with genomics/genetics, transcriptomics, proteomics, metabolomics, inflammation, oxidative stress, neurotrophic factors, cytokines, cognition, neurocognition, and neuroimaging. Papers were selected from the initial search if the primary outcome(s) of interest was (were) categorized in any of the following domains: (i) ?omics? (e.g., genomics), (ii) molecular, (iii) neuroimaging, and (iv) neurocognitive. Results The current strategic approach to identifying individuals at risk for BD, with an emphasis on phenotypic information and family history, has insufficient predictive validity and is clinically inadequate. The heterogeneous clinical presentation of BD, as well as its pathoetiological complexity, suggests that it is unlikely that a single biomarker (or an exclusive biomarker approach) will sufficiently augment currently inadequate phenotypic-centric prediction models. We propose a ?Big Data?- bioinformatics approach that integrates vast and complex phenotypic, anamnestic, behavioral, family, and personal ?omics? profiling. Bioinformatic processing approaches, utilizing cloud- and grid-enabled computing, are now capable of analyzing data on the order of tera-, peta-, and exabytes, providing hitherto unheard of opportunities to fundamentally revolutionize how psychiatric disorders are predicted, prevented, and treated. High-throughput networks dedicated to research on, and the treatment of, BD, integrating both adult and younger populations, will be essential to sufficiently enroll adequate samples of individuals across the neurodevelopmental trajectory in studies to enable the characterization and prevention of this heterogeneous disorder. Conclusions Advances in bioinformatics using a ?Big Data? approach provide an opportunity for novel insights regarding the pathoetiology of BD. The coordinated integration of research centers, inclusive of mixed-age populations, is a promising strategic direction for advancing this line of neuropsychiatric research.
ER  - 

TY  - JOUR
AU  - Dubin, Patricia J.
AU  - Kolls, Jay K.
TI  - Th17 cytokines and mucosal immunity
JO  - Immunological Reviews
VL  - 226
IS  - 1
SN  - 0105-2896
UR  - https://doi.org/10.1111/j.1600-065X.2008.00703.x
DO  - doi:10.1111/j.1600-065X.2008.00703.x
SP  - 160
EP  - 171
KW  - Th17
KW  - IL-17A
KW  - IL-17F
KW  - IL-22
KW  - vaccine
KW  - mucosa
PY  - 2008
AB  - Summary: The T-helper 17 (Th17) lineage is a recently described subset of memory T cells that is characterized by its CD4+ status and its ability to make a constellation of cytokines including interleukin-17A (IL-17A), IL-17F, IL-22, and, in humans, IL-26. Although most extensively described in the autoimmunity literature, there is growing evidence that the Th17 lineage plays a significant role in mediating host mucosal immunity to a number of pulmonary pathogens. This review highlights our current understanding of the role of the Th17 lineage and Th17 cytokines in mediating mucosal immunity to both pulmonary and gastrointestinal pathogens. While we have the strongest evidence that the Th17 lineage is centrally involved in mediating the host response to Gram-negative extracellular pulmonary pathogens, this literature is rapidly evolving and demonstrates a central role for Th17 cytokines both in primary infection and in recall responses seen in vaccine studies. In this review, we summarize the current state of this literature and present possible applications of Th17-targeted immunotherapy in the treatment and prevention of infection.
ER  - 

TY  - JOUR
TI  - Cell biochemistry
JO  - European Journal of Biochemistry
VL  - 271
IS  - s1
SN  - 0014-2956
UR  - https://doi.org/10.1111/j.1474-3833.2004.4121.x
DO  - doi:10.1111/j.1474-3833.2004.4121.x
SP  - 126
EP  - 204
PY  - 2004
ER  - 

TY  - JOUR
TI  - 2014 ASPHO Abstracts
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 61
IS  - S1
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.25032
DO  - doi:10.1002/pbc.25032
SP  - S1
EP  - S104
PY  - 2014
ER  - 

TY  - JOUR
TI  - Oral and Poster Abstracts
JO  - Journal of Thrombosis and Haemostasis
VL  - 4
IS  - s1
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2006.02306.x
DO  - doi:10.1111/j.1538-7836.2006.02306.x
SP  - 67
EP  - 243
PY  - 2006
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Journal of Clinical Periodontology
JA  - J Clin Periodontol
VL  - 39
IS  - s13
SN  - 0303-6979
UR  - https://doi.org/10.1111/j.1600-051x-2012.01891.x
DO  - doi:10.1111/j.1600-051x-2012.01891.x
SP  - 76
EP  - 404
PY  - 2012
ER  - 
